FILGRASTIM INJECTION 300MCG
| Generic Name | Filgrastim |
| Strength | 300 mcg |
| Dosage Form | Injection |
| Route of Administration | Subcutaneous / Intravenous |
| Therapeutic Class | Hematopoietic Agent / Colony-Stimulating Factor |
| Indications | Chemotherapy-induced neutropenia, bone marrow transplant, severe chronic neutropenia |
| Prescription Required | Yes |
| Storage | Store refrigerated at 2°C–8°C; do not freeze |
| Manufacturer | As per the pack details |
FILGRASTIM INJECTION 300MCG
Filgrastim Injection 300mcg is a prescription biologic medicine belonging to the granulocyte colony-stimulating factor (G-CSF) class. It is commonly used in patients undergoing chemotherapy or bone marrow transplantation or those with severe chronic neutropenia. This injection is an essential therapy for boosting the immune system and preventing infections in vulnerable patients.
Filgrastim 300 mcg Injection works by stimulating the bone marrow to produce more neutrophils, a type of white blood cell crucial for fighting infections. Increasing neutrophil counts, it helps reduce the risk of serious infections and supports faster recovery of the immune system during cancer treatment.
Administered under strict medical supervision, Filgrastim 300 mcg Injection is typically given as a subcutaneous or intravenous injection. Healthcare professionals determine the dosage and schedule based on the patient’s condition, ensuring effective immune support while minimizing potential side effects.
Product Features
- Recombinant human G-CSF formulation
- Stimulates neutrophil production
- Reduces chemotherapy-induced neutropenia
- Helps lower infection risk
- Injectable biologic therapy
- Prescription-only medication
How It Helps
- Boosts neutrophil production to strengthen the immune system
- Reduces the risk of infections during chemotherapy or bone marrow transplant
- Helps recover white blood cell counts faster after cancer treatment
- Supports long-term management of chronic neutropenia





Reviews
There are no reviews yet.